MarketCap
Facebook
X
Telegram
Genetron Holdings Limited Shares | GTH
Annual Shares Genetron Holdings Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 464 M | 461 M | 301 M | 125 M | 114 M | 67.7 M | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 464 M | 67.7 M | 255 M |
Quarterly Shares Genetron Holdings Limited
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 464 M | - | - | - | 461 M | - | - | - | 301 M | - | - | - | 125 M | - | - | - | 114 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 464 M | 114 M | 293 M |
Shares of other stocks in the Diagnostics research industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
50.9 K | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
10.3 M | - | - | $ 1.31 B | USA |
 |
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | USA |
|
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
34.1 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
23.3 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M |  Britain |
 |
Chembio Diagnostics
CEMI
|
32.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
6.23 M | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
889 K | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
122 M | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
74.3 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
132 M | - | - | $ 7.1 B |  Australia |
 |
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | USA |
 |
Exact Sciences Corporation
EXAS
|
189 M | - | - | $ 19.8 B | USA |
 |
QIAGEN N.V.
QGEN
|
217 M | - | - | $ 10.6 B |  Niderland |
 |
Soleno Therapeutics
SLNO
|
50.8 M | - | - | $ 2.69 B | USA |
 |
Motus GI Holdings
MOTS
|
1.55 M | - | -34.28 % | $ 263 K | Israel |
 |
Invitae Corporation
NVTA
|
236 M | - | - | $ 21.2 M | USA |
 |
Organovo Holdings
ONVO
|
1.46 M | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
10.1 M | - | -16.95 % | $ 1.54 M | USA |
 |
PerkinElmer
PKI
|
117 M | - | -0.91 % | $ 14.7 B | USA |
 |
Psychemedics Corporation
PMD
|
5.87 M | - | -1.84 % | $ 15.3 M | USA |
 |
Quotient Limited
QTNT
|
102 M | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
T2 Biosystems
TTOO
|
2.61 M | - | -39.35 % | $ 313 K | USA |
 |
Renalytix AI plc
RNLX
|
108 M | - | 5.66 % | $ 22.7 M | Britain |
 |
Syneos Health
SYNH
|
103 M | - | - | $ 4.46 B | USA |
 |
Meridian Bioscience
VIVO
|
43.6 M | - | - | $ 1.49 B | USA |
 |
Surmodics
SRDX
|
14.2 M | - | - | $ 608 M | USA |
 |
Agilent Technologies
A
|
284 M | $ 127.06 | 2.2 % | $ 36.1 B | USA |
 |
Anixa Biosciences
ANIX
|
32.5 K | $ 2.91 | 8.18 % | $ 94.4 K | USA |
|
Biodesix
BDSX
|
7.55 M | $ 16.81 | 10.45 % | $ 127 M | USA |
 |
Biomerica
BMRA
|
2.3 M | $ 1.79 | -9.14 % | $ 4.11 M | USA |
 |
BioNano Genomics
BNGO
|
5.44 M | $ 1.14 | -1.72 % | $ 6.21 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
82.1 M | $ 7.25 | 2.98 % | $ 76.5 M | China |
 |
Bioventus
BVS
|
66.6 M | $ 8.71 | 1.99 % | $ 580 M | USA |
 |
Brainsway Ltd.
BWAY
|
34 M | $ 14.89 | 3.33 % | $ 506 M | Israel |
 |
CareDx, Inc
CDNA
|
53.3 M | $ 26.18 | 11.5 % | $ 1.4 B | USA |
 |
Celcuity
CELC
|
46.8 M | $ 87.76 | -0.33 % | $ 4.1 B | USA |
 |
Co-Diagnostics
CODX
|
1.33 M | $ 3.37 | 1.2 % | $ 4.48 M | USA |
 |
Charles River Laboratories International
CRL
|
49.6 M | $ 185.0 | 1.46 % | $ 9.17 B | USA |
 |
Castle Biosciences
CSTL
|
29 M | $ 21.12 | 4.3 % | $ 612 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
111 M | $ 195.0 | -1.4 % | $ 21.6 B | USA |
 |
Danaher Corporation
DHR
|
713 M | $ 177.17 | -0.33 % | $ 126 B | USA |
 |
DarioHealth Corp.
DRIO
|
3.98 M | $ 6.93 | -2.81 % | $ 27.6 M | Israel |
 |
DexCom
DXCM
|
390 M | $ 72.47 | 1.74 % | $ 28.3 B | USA |
 |
Fulgent Genetics
FLGT
|
30.8 M | $ 18.0 | 1.69 % | $ 554 M | USA |